NANO-OJAS Trademark

Trademark Overview


On Thursday, June 16, 2016, a trademark application was filed for NANO-OJAS with the United States Patent and Trademark Office. The USPTO has given the NANO-OJAS trademark a serial number of 87073835. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, May 18, 2023. This trademark is owned by NANORX INC.. The NANO-OJAS trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic and muscle relaxant nutraceutical preparations; Anti-diabetic nutraceuticals; Cardiovascular nutraceuticals; Nutraceutical preparations for the treatment of gout; Nutraceutical preparations and substances for the treatment of gastro-intestinal diseases; Nutraceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceutical preparations for inhalation for the treatment of pulmonary hypertension; Nutraceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-v...
nano-ojas

General Information


Serial Number87073835
Word MarkNANO-OJAS
Filing DateThursday, June 16, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, May 18, 2023
Registration Number5105133
Registration DateTuesday, December 20, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2016

Trademark Statements


Goods and ServicesAnalgesic and muscle relaxant nutraceutical preparations; Anti-diabetic nutraceuticals; Cardiovascular nutraceuticals; Nutraceutical preparations for the treatment of gout; Nutraceutical preparations and substances for the treatment of gastro-intestinal diseases; Nutraceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Nutraceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Nutraceutical preparations for inhalation for the treatment of pulmonary hypertension; Nutraceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Nutraceutical preparations for the treatment of inflammatory disorders; Nutraceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Nutraceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Nutraceutical preparations for the prevention of diabetes; Nutraceutical preparations for the treatment of eye diseases and conditions; Nutraceutical preparations for the treatment of heart rhythm disorders; Nutraceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Nutraceutical preparations for the treatment of infectious diseases; Nutraceutical preparations for the treatment of hypertension; Nutraceutical preparations for treating allergic rhinitis and asthma; Nutraceutical preparations for treating diabetes; Nutraceutical preparations for treating skin disorders; Nutraceutical preparations for use in urology; Nutraceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Nutraceutical products for ophthalmological use; Nutraceutical products for the treatment of bone diseases; Nutraceutical products for the treatment of joint disease; Nutraceutical products for the treatment of viral and infectious diseases; Nutraceutical preparations for the treatment of cancer; Nutraceutical products for treating respiratory diseases and asthma; Nutraceutical solutions used in dialysis; Nutraceuticals, namely, lipid lowering agents; Plant extracts for medical, veterinary and nutraceutical purposes; Therapeutic nutraceuticals for the treatment of obesity

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 22, 2016
Primary Code005
First Use Anywhere DateWednesday, May 21, 2014
First Use In Commerce DateWednesday, May 21, 2014

Trademark Owner History


Party NameNANORX INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChappaqua, NY 10514

Party NameNANORX INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChappaqua, NY 10514

Party NameNANORX INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChappaqua, NY 10514

Trademark Events


Event DateEvent Description
Thursday, May 18, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, May 18, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, May 18, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, November 3, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, December 20, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 20, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, October 5, 2016CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, October 4, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 4, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2016ASSIGNED TO EXAMINER
Tuesday, September 27, 2016ASSIGNED TO PETITION STAFF
Thursday, September 15, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, September 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 30, 2016ASSIGNED TO LIE
Monday, August 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 15, 2016EXAMINER'S AMENDMENT ENTERED
Monday, August 15, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 15, 2016EXAMINERS AMENDMENT E-MAILED
Monday, August 15, 2016EXAMINERS AMENDMENT -WRITTEN
Monday, August 15, 2016ASSIGNED TO EXAMINER
Wednesday, June 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 20, 2016NEW APPLICATION ENTERED